Synthesis of [l-Nal3] thymopoietin II and examination of its immunological effect on the uremic T-lymphocytes

A TP II analogue, [l-Nal3] TP II, was synthesized by a conventional solution method, followed by deprotection with 1M TFMSA-thioanisole (molar ratio 1:1) in TFA in the presence of Me2Se and m-cresol as scavengers. The synthetic [l-Nal3] TP II, TP II and [Phe (4 F)3] TP II were tested for comparative...

Full description

Saved in:
Bibliographic Details
Main Authors: T. Abiko, S. Nakatsubo
Format: Article
Language:English
Published: Wiley 2000-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1080/09629350020002930
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564179223969792
author T. Abiko
S. Nakatsubo
author_facet T. Abiko
S. Nakatsubo
author_sort T. Abiko
collection DOAJ
description A TP II analogue, [l-Nal3] TP II, was synthesized by a conventional solution method, followed by deprotection with 1M TFMSA-thioanisole (molar ratio 1:1) in TFA in the presence of Me2Se and m-cresol as scavengers. The synthetic [l-Nal3] TP II, TP II and [Phe (4 F)3] TP II were tested for comparative effect on the impaired T-lymphocyte transformation by PHA in uremic patients suffering from recurrent infectious diseases. The synthetic analogue was found to have stronger restorative activity than those of our synthetic TP II and [Phe (4 F)3] TP II.
format Article
id doaj-art-2911084bc49a4c51b361e9b2b4b0a895
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2000-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-2911084bc49a4c51b361e9b2b4b0a8952025-02-03T01:11:32ZengWileyMediators of Inflammation0962-93511466-18612000-01-0193-420120610.1080/09629350020002930Synthesis of [l-Nal3] thymopoietin II and examination of its immunological effect on the uremic T-lymphocytesT. Abiko0S. Nakatsubo1Research Laboratory, Global Shinwa Pharmaceutical Co. Ltd, 2–546–1, Yoriki, Matsuomura, Iwate-gun, Iwate-ken, 028–7302, JapanResearch Laboratory, Global Shinwa Pharmaceutical Co. Ltd, 2–546–1, Yoriki, Matsuomura, Iwate-gun, Iwate-ken, 028–7302, JapanA TP II analogue, [l-Nal3] TP II, was synthesized by a conventional solution method, followed by deprotection with 1M TFMSA-thioanisole (molar ratio 1:1) in TFA in the presence of Me2Se and m-cresol as scavengers. The synthetic [l-Nal3] TP II, TP II and [Phe (4 F)3] TP II were tested for comparative effect on the impaired T-lymphocyte transformation by PHA in uremic patients suffering from recurrent infectious diseases. The synthetic analogue was found to have stronger restorative activity than those of our synthetic TP II and [Phe (4 F)3] TP II.http://dx.doi.org/10.1080/09629350020002930
spellingShingle T. Abiko
S. Nakatsubo
Synthesis of [l-Nal3] thymopoietin II and examination of its immunological effect on the uremic T-lymphocytes
Mediators of Inflammation
title Synthesis of [l-Nal3] thymopoietin II and examination of its immunological effect on the uremic T-lymphocytes
title_full Synthesis of [l-Nal3] thymopoietin II and examination of its immunological effect on the uremic T-lymphocytes
title_fullStr Synthesis of [l-Nal3] thymopoietin II and examination of its immunological effect on the uremic T-lymphocytes
title_full_unstemmed Synthesis of [l-Nal3] thymopoietin II and examination of its immunological effect on the uremic T-lymphocytes
title_short Synthesis of [l-Nal3] thymopoietin II and examination of its immunological effect on the uremic T-lymphocytes
title_sort synthesis of l nal3 thymopoietin ii and examination of its immunological effect on the uremic t lymphocytes
url http://dx.doi.org/10.1080/09629350020002930
work_keys_str_mv AT tabiko synthesisoflnal3thymopoietiniiandexaminationofitsimmunologicaleffectontheuremictlymphocytes
AT snakatsubo synthesisoflnal3thymopoietiniiandexaminationofitsimmunologicaleffectontheuremictlymphocytes